Add Yahoo as a preferred source to see more of our stories on Google. Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since ...
In a little noticed move, the company that sells the Addyi pill for female sexual dysfunction recently won regulatory approval in Canada, thanks to a followup study designed to address a nagging ...
The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...
Four years after approving the controversial Addyi pill for female sexual dysfunction, the Food and Drug Administration on Thursday softened a safety warning about mixing the drug with alcohol. But ...
Three years ago, the holy grail for women with a low sex drive seemed to have arrived. A little pink pill called Addyi—pronounced add-ee and erroneously nicknamed the female Viagra—was the first ...
The FDA has approved a controversial drug designed to enhance a woman’s sexual drive. Addyi (generic name: flibanserin), from Sprout Pharmaceuticals, acts in the brain to enhance a woman’s libido. By ...
After a ton of controversy, the female libido pill Addyi is finally available by prescription, which means that studies of patients using Addyi are starting to trickle in. One such study, which pooled ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. When Kara became disinterested in sex with her husband, she knew their relationship wasn't the problem ...
U.S. health authorities have widened the approval of a closely debated medication designed to increase female libido, allowing the once-daily pill to be used by women over the age of 65. The decision, ...
WASHINGTON -- Drinking alcohol with the female libido booster flibanserin (Addyi) appears somewhat less dangerous than initially thought and the FDA has ordered a label change to reflect the new data ...